Preliminary program, Hilton Istambul Bomonti, Tukey

Joint conference Haematopoiesis Immunology & EHOG
“MRD diagnosis and treatment in tumors of haematopoietic and lymphoid tissues”
October 5, 2022
Istanbul
UTC +3


9.00 – 9.15 Opening Ceremony
Professor George Janossy (UK)
Professor Robert Gale (USA)
Professor Nikolai Tupitsyn (Russia)
Professor Irina Poddubnaya (Russia) - President of Russian oncohaematology Society
Chairmen:
Professor George Janossy (UK)
Professor Robert Gale (USA)
Professor Dieter Hoelzer (Germany)
Professor Nikolai Tupitsyn

9.15 – 9.35 Professor Robert Gale (USA)
“Should MRD be an endpoint of CLL therapy?”
9.35 – 9.55 Professor Jean-Francois Rossi (France)
“How the evaluation of minimal residual disease may influence a clinical decision?”
9.55 – 10.15 Professor Dieter Hoelzer (Germany)
“Modern possibilities of MRD eradication in oncohematology. Which acute leukemia may be treated immunologically w/o chemotherapy?”
10.15 – 10.35 Vera S. Donnenberg (USA)
“Localized conditioning of pleural environment”
10.35 – 10.55 Alexandra Palladina (Russia)
“General principles of MRD monitoring in AML”
10.55 – 11.10 Coffee break
11.10 – 11.30 Mary Shervashidze (co-authored with Alexandra Palladina, T.T. Valiev) (Russia)
“Prognostic significance of MRD in children B-All at post-induction period”
11.30 – 11.50 Kapitolina Melkova (co-authored with Zhanna Sharoyan) (Russia)
“Umbilical cord blood NK-cells”
11.50 – 12.10 Professor Nikolai Tupitsyn
“Modern approaches to hematogeneous metastasis prevention and cancer immune prophylaxis”
12.10 – 12.30 Vladimir Jurisic (Serbia)
“Multiomic cytokine analysis in hemato-immunology”
12.30 – 13.00 General discussion